Protagenic Therapeutics, Inc. PTIXW
0.02 USD 0.00 (+0.00%)
Jan 2, 2026, 2:01 PM EST
0.015 Day range 0.026
52-week range unavailable
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 27.16K
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 24.02K
- Open
- 0.026
- Previous close
- 0.015
- Day's range
- 0.015 – 0.026
- Beta
- 0.25
No chart data for this range yet.
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.01
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -3.12M
- Total cash
- 924.60K
- Total debt
- 0
- Return on equity
- -206.36%
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Consensus EPS estimate 0.00.
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- protagenic.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on PTIXW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Warberg Asset Management LLC | 5.57% | 177,196 | 1.01K | Sep 29, 2024 |
| Susquehanna International Group, LLP | 1.47% | 46,615 | 265 | Sep 29, 2024 |
| Gts Securities LLC | 0.80% | 25,300 | 144 | Sep 29, 2024 |